Introduction {#sec1-1}
============

Early detection and treatment of high grade cervical intraepithelial neoplasia (CIN 2-3) is known to prevent the development of cervical cancer (Pinto and Crum, 2000; Massad et al., 2013). Management options for CIN 2-3 are ablation and excision in which both techniques have a comparable efficacy (Massad et al., 2013). However, the excisional method offers more advantages, including obtaining a specimen for pathological assessment and indicating a complete removal of lesion (Kyrgiou et al., 2006; Soutter et al., 2006; Martin-Hirsch et al., 2013). Many techniques of the excisional method are available, including loop electrosurgical excision procedure (LEEP), laser excision and cold-knife conization (Martin-Hirsch et al., 2013). LEEP is preferably used for treating CIN 2-3 lesions because it is safe, cost-effective and practical to perform under local anesthesia in an outpatient setting (Eduardo et al., 1996).

Pathological findings of LEEP specimens are often correlated with the results of colposcopic directed biopsy-confirmed CIN 2-3. However, some LEEP specimens of patients with colposcopic directed biopsy-confirmed CIN 2-3 reveal only CIN 1 or less. Previous studies have reported that there were 14-24% of patients with colposcopic directed biopsy-confirmed CIN 2-3 had CIN 1 or less in LEEP specimens (Ryu et al., 2010; Witt et al., 2012; Rodriguez-Manfredi et al., 2013; Giannella et al., 2015; Nam et al., 2015; Zhang et al., 2015). Therefore, routine treatment of all patients with biopsy-confirmed CIN 2-3 by using LEEP may result in overtreatment. Although LEEP is a safe excision procedure, it may carry complications, including bleeding, infection, incompetent cervix and cervical stenosis. These complications may result in an increased risk of future pregnancy problems.

The objectives of this study were to determine the frequency of CIN 1 or less in LEEP specimens of women with colposcopic directed biopsy-confirmed CIN 2-3 and to evaluate the predicting factors of having CIN 1 or less in these LEEP specimens.

Materials and Methods {#sec1-2}
=====================

This retrospective study was undertaken at the Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University Hospital (a tertiary hospital), Thailand. The study was approved by the Institutional Review Board of the Faculty of Medicine, Thammasat University Hospital and conformed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network guidelines. Women with abnormal Papanicolaou (Pap) test who had been diagnosed with CIN 2-3 by colposcopic directed biopsy and subsequently underwent LEEP between January 2012 and December 2017 were included in the study. Pregnant women, patients who had a history of precancerous or cancerous lesion of the cervix, patients who had previous cervical surgery or hysterectomy and patients who had hysterectomy within 3 months after LEEP were excluded.

All related clinical data were collected. The collected data included demographic data, Pap test results, colposcopic findings, pathological diagnoses of colposcopic directed biopsy and LEEP, and time interval from colposcopic directed biopsy to LEEP.

All colposcopic examinations and LEEP were performed by gynecologic oncologists. LEEP specimens were prepared by serial cutting in 2-3-millimeter thickness for pathological examination. The colposcopic directed biopsy and LEEP pathology were retrieved for review by a pathologist (AS) and final diagnosis was established with agreement of AS and the previous pathologist's report. If the final diagnosis of the colposcopic directed biopsy specimens was not CIN 2-3, they were excluded. Pathological discrepancy was defined as having CIN 2-3 in colposcopic directed biopsy specimens, but no dysplasia or having CIN 1 in LEEP specimens.

Post-LEEP follow-up using Pap test was performed every 6-12 months during the first 2 years. Patients who were lost to follow-up were excluded from the study. Persistent or recurrent disease was defined as having histological diagnosis of CIN 2-3 during the follow-up.

The sample size was calculated by using the single proportion formula, based on the prevalence of pathological discrepancy from the previous study which was 24% (Ryu et al., 2010; Witt et al., 2012; Rodriguez-Manfredi et al., 2013; Giannella et al., 2015; Nam et al., 2015; Zhang et al., 2015). Applying an acceptable error of 5%, the sample size was 280. Statistical analyses were performed using the Statistical Package for the Social Sciences software (IBM Corp., Armonk, NY, USA). Descriptive statistics were used to analyze clinical data of the patients. Associations between clinical factors and CIN 1 or less in LEEP specimens were analyzed using Chi-square test, Student-t test and logistic regression analyses. A p value of less than 0.05 was considered statistically significant.

Results {#sec1-3}
=======

There were 280 patients with colposcopic directed biopsy-confirmed CIN 2-3 included in the study. Clinical characteristics are summarized in [Table 1](#T1){ref-type="table"}. Mean (SD) age of the patients was 35.8 (9.1) years. There were 125 (44.6%) patients with low grade Pap results, including atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) and 155 (55.4%) patients with high grade Pap results, including high grade squamous intraepithelial lesion (HSIL), atypical squamous cells cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), squamous cell carcinoma and adenocarcinoma. Histological diagnosis from colposcopic directed biopsy specimens were CIN 2 in 115 (41.1%) patients and CIN 3 in 165 (58.9%) patients. LEEP histologic results were 30 (10.7%) patients with no dysplasia, 41 (14.7%) patients with CIN 1, 32 (11.4%) patients with CIN 2 and 177 (63.2%) patients with CIN 3. Neither adenocarcinoma in situ (AIS) nor cancer was detected in LEEP specimens.

###### 

Clinical Characteristics of Enrolled Patients (N= 280)

  Characteristics                     Value
  ----------------------------------- ------------
  Age, mean±SD (years)                35.8±9.1
  Parity                              
   Nulliparous                        119 (42.5)
   Multiparous                        161 (57.5)
  Menopausal status                   
   Premenopause                       256 (91.4)
   Postmenopause                      24 (8.6)
  Papanicolaou test                   
   ASC-US                             61 (21.8)
   LSIL                               64 (22.8)
   HSIL                               110 (39.3)
   ASC-H                              34 (12.1)
   AGC                                1 (0.4)
   Cancer                             10 (3.6)
  Colposcopy                          
   Satisfactory                       169 (60.4)
   Unsatisfactory                     111 (39.6)
  Colposcopic impression              
   Low grade                          111 (39.6)
   High grade                         169 (60.4)
  Colposcopic directed biopsy         
   CIN 2                              115 (41.1)
   CIN 3                              165 (58.9)
  LEEP results                        
   No dysplasia                       30 (10.7)
   CIN 1                              41 (14.7)
   CIN 2                              32 (11.4)
   CIN 3                              177 (63.2)
   AIS/cancer                         0 (0)
  Margin                              
   Free                               178 (63.6)
   Involved by CIN 1                  7 (2.5)
   Involved by CIN 2-3                95 (33.9)
  Time interval from biopsy to LEEP   
   1 month                            104 (37.1)
   2 months                           95 (33.9)
   ≥3 months                          81 (29.0)
  Recurrent/persistent disease        
   No                                 264 (94.3)
   CIN 1                              13 (4.6)
   CIN 2-3                            3 (1.1)

Values are presented as N (%); ASC-US, atypical squamous cells of undetermined significance; LSIL, low grade squamous intraepithelial lesions; HSIL, high grade squamous intraepithelial lesions; ASC-H, atypical squamous cells cannot exclude HSIL; AGC, atypical glandular cells; CIN, cervical intraepithelial neoplasia; AIS, adenocarcinoma in situ; LEEP, loop electrosurgical excision procedure.

Predictors of CIN 1 or less in LEEP specimens {#sec2-1}
---------------------------------------------

Pathological discrepancy was found in 71 out of 280 patients (25.4%). Risk factors for having pathological discrepancy are presented in [Table 2](#T2){ref-type="table"}. Increased age, nulliparity, low grade Pap results, low grade colposcopic impression, CIN 2 on colposcopic directed biopsy and increased time interval between biopsy and LEEP were significantly associated with CIN 1 or less in LEEP specimens. Multivariate logistic regression analyses showed that nulliparity, low grade Pap results and low grade colposcopic impression were associated with CIN 1 or less in LEEP specimens \[OR (95%CI): 3.375 (1.245-9.150), p = 0.017; 6.410 (2.877-14.280), p \<0.001 and 16.509 (5.844-46.632), p \<0.001, respectively\] ([Table 3](#T3){ref-type="table"}).

###### 

Clinical Characteristics of Patients According to Loop Electrosurgical Excision Procedure (LEEP) Pathology

                                                 LEEP pathology                
  ---------------------------------------------- ---------------- ------------ ---------
  Age, mean±SD (years)                           32.1±7.1         37.1±9.3     \<0.001
  Parity                                                                       
   Nulliparous                                   45 (63.4)        74 (35.4)    \<0.001
   Multiparous                                   26 (36.6)        135 (64.6)   
  Menopausal status                                                            
   Premenopause                                  65 (91.5)        191 (91.4)   0.970
   Postmenopause                                 6 (8.5)          18 (8.6)     
  Papanicolaou test                                                            
   Low grade^[a](#t2f1){ref-type="table-fn"}^    54 (76.1)        71 (34.0)    \<0.001
   High grade^[b](#t2f2){ref-type="table-fn"}^   17 (23.9)        138 (66.0)   
  Colposcopy                                                                   
   Satisfactory                                  37 (52.1)        132 (63.2)   0.100
   Unsatisfactory                                34 (47.9)        77 (36.8)    
  Colposcopic impression                                                       
   Low grade                                     60 (84.5)        51 (24.4)    \<0.001
   High grade                                    11 (15.5)        158 (75.6)   
  Colposcopic directed biopsy                                                  
   CIN 2                                         55 (77.5)        60 (28.7)    \<0.001
   CIN 3                                         16 (22.5)        149 (71.3)   
  Recurrent/persistent disease                                                 
   No/CIN 1                                      71 (100.0)       206 (98.6)   0.310
   CIN 2-3                                       0 (0)            3 (1.4)      
  Time interval from biopsy to LEEP                                            
   1 month                                       17 (24.0)        87 (41.6)    \<0.001
   2 months                                      29 (40.8)        66 (31.6)    
   ≥3 months                                     25 (35.2)        56 (26.8)    

Values are presented as N (%);

Low grade Papanicolaou test, atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesions (LSIL);

High grade Papanicolaou test, high grade squamous intraepithelial lesions (HSIL); atypical squamous cells cannot exclude HSIL (ASC-H); atypical glandular cells (AGC) and cancer; CIN, cervical intraepithelial neoplasia.

###### 

Multivariate Logistic Regression Analyses of Risk Factors for Predicting an Absence of High Grade Dysplasia in Loop Electrosurgical Excision Procedure (LEEP) Specimens

                                       95% confidence interval                    
  ------------------------------------ ------------------------- ------- -------- ---------
  Age                                  0.959                     0.882   1.042    0.326
  Parity: nulliparity                  3.375                     1.245   9.150    0.017
  Papanicolaou test: low grade         6.410                     2.877   14.280   \<0.001
  Colposcopic impression: low grade    16.509                    5.844   46.632   \<0.001
  Colposcopic directed biopsy: CIN 2   1.351                     0.344   5.303    0.666
  Time interval from biopsy to LEEP    0.678                     0.217   2.118    0.504

OR, odds ratio

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of nulliparity, low grade Pap results and low grade colposcopic impression for predicting the absence of high-grade CIN in LEEP specimens are shown in [Table 4](#T4){ref-type="table"}. Low grade colposcopic impression was found to be the most sensitive (85%) and specific (76%).

###### 

Sensitivity Analyses of Risk Factors for Predicting an Absence of High-grade CIN in LEEP Specimens

  Risk factors                       Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)
  ---------------------------------- ----------------- ----------------- --------- ---------
  Nulliparity                        63                64                37        83
  Low grade Pap test                 76                66                43        89
  Low grade colposcopic impression   85                76                54        93

PPV, positive predictive value; NPV, negative predictive value; CIN, cervical intraepithelial neoplasia; LEEP, loop electrosurgical excision procedure

Follow-up data {#sec2-2}
--------------

Median (range) follow-up time of patients who had LEEP specimens with CIN 1 or less (N = 71) and CIN 2-3 (N = 209) were 10 (6-17) months and 12 (7-14) months, respectively.

Out of 71 patients with CIN 1 or less in LEEP specimens, 1 (1.4%) had abnormal cervical cytology with followed-up colposcopic directed biopsy not found CIN 2-3. Among 209 patients with CIN 2-3 in LEEP specimens, 7 (3.3%) and 19 (9.1%) had abnormal cervical cytology defined as low grade and high grade, respectively. Out of 26 patients with abnormal cervical cytology, 3 patients had CIN 2-3. Therefore, persistent or recurrent CIN 2-3 was diagnosed in 3 (1.4%) of 26 patients with CIN 2-3 in LEEP specimens. However, no persistent or recurrent CIN 2-3 disease was detected in patients with CIN 1 or less in LEEP specimens.

Discussion {#sec1-4}
==========

Current recommendations by the American Society for Colposcopy and Cervical Pathology (ASCCP) suggest that patients with CIN 2-3 diagnosed by colposcopic directed biopsy should be treated with excision or ablation (Massad et al., 2013). The reasons for the recommendations are lower rate of spontaneous regression and risk of progression to cancer especially CIN 3 lesions (Massad et al., 2013). LEEP is one of the excisional methods for the treatment of these lesions. The minority of patients with CIN 2-3 on colposcopic directed biopsy have no dysplasia or have only CIN 1 in subsequent LEEP specimens. This study showed 25.4% of CIN 1 or less in LEEP specimens of patients with colposcopic directed biopsy-confirmed CIN 2-3. Previous studies have reported the prevalence of 14-24% of pathological discrepancy (Ryu et al., 2010; Witt et al., 2012; Rodriguez-Manfredi et al., 2013; Giannella et al., 2015; Nam et al., 2015; Zhang et al., 2015; Noothong et al., 2017). The rates of pathological discrepancy varied because of differences in studied population and definition of pathological discrepancy among studies. This study defined pathological discrepancy as the diagnosis of CIN 2-3 in colposcopic directed biopsy specimens, but identification of CIN 1 or less in LEEP specimens. On the other hand, some studies defined pathological discrepancy as only an absence of dysplasia found in LEEP specimens in patients with colposcopic directed biopsy-confirmed CIN 2-3 (Ryu et al., 2010; Nam et al., 2015). Absence of high grade CIN in LEEP specimens despite having high grade CIN in colposcopic directed biopsy specimens might be caused by several reasons. First, CIN lesion was small and it was completely removed by the biopsy procedure (Li et al., 2009). Second, misdiagnosis of LEEP specimens or high grade CIN was not removed by LEEP (Ryu et al., 2010), Third, the remaining lesion might spontaneously regress (Melnikow et al., 1998; Li et al., 2009).

Multivariate logistic regression analyses of this study found that nulliparity, low grade Pap results and low grade colposcopic impression were the predicting factors of having CIN 1 or less in LEEP specimens. However, there was no association between CIN 2 in colposcopic directed biopsy specimens and CIN 1 or less in LEEP specimens. This finding was different from that of most previous studies which have shown CIN 2 in colposcopic directed biopsy specimens was the predicting factor of having CIN 1 or less in LEEP specimens (Giannella et al., 2015; Nam et al., 2015; Zhang et al., 2015; Noothong et al., 2017). Our study found that low grade colposcopic impression was a predicting factor of having CIN 1 or less in LEEP specimens. This finding was in agreement with the study of Giannella et al., (2015) in which they demonstrated that CIN 2 on cervical biopsy and low grade colposcopic impression were predictors of minor cone histology. In addition, study of prognostic value of colposcopic impression showed that patients with low grade Pap results and normal colposcopic impression had a low risk of having high grade CIN within 3 years (Cruickshank et al., 2015).

The follow-up data of this study showed no persistent or recurrent CIN 2-3 in patients who had CIN 1 or less in LEEP specimens. However, this result was different from that of the study by Giannella et al., (2015). Giannella et al., (2015) reported that recurrence rates of high grade CIN were 7.4% and 10.6% in patients who had CIN 1 or less and CIN 2-3 in LEEP specimens, respectively. Therefore, patients with both CIN 2-3 and CIN 1 or less in LEEP specimens following a biopsy diagnosis of CIN 2-3 should be similarly followed up.

Regarding fertility-sparing approach for preservation of reproductive potential of the patients, the impact of treatment on quality of life and psychological issue of these patients should be considered (Vitale et al., 2017; Chiofalo et al., 2017).

The strength of this study was that all histologic slides of cervical biopsy and LEEP were reviewed by a pathologist. However, there were some limitations, including being a retrospective design, and lack of data on size and position of cervical lesions, size of LEEP specimens and Human papillomavirus (HPV) testing results. HPV testing was not performed in a majority of patients enrolled in this study.

Several biomarkers such as p16ink4a, p16 and Ki67, which were demonstrated to be predictors of intraepithelial lesions, have more chance to develop to invasive forms (Vitale et al., 2016; Valenti et al., 2017; Nicol et al., 2018). In addition, p16ink4a immunohistochemistry was presented in low grade lesions associated with high risk HPV types which have a high risk of progression (Vitale et al., 2016; Valenti et al., 2017). Furthermore, p16 immunostaining was shown to reduce the frequency of negative LEEP after CIN 2-3 diagnoses of cervical colposcopic biopsies (de Sam Lazaro et al., 2016). However, our study did not investigate these specific biomarkers.

In conclusion, approximately 25% of patients with CIN 2-3 in colposcopic directed biopsy specimens had CIN 1 or less found in LEEP specimens. Nulliparity, low grade Pap results and low grade colposcopic impression were predicting factors of CIN 1 or less in LEEP specimens. Although LEEP is a safe procedure, it may carry a risk of future reproductive problems (Vitale et al., 2017). These findings could be useful for guiding treatment options and reducing unnecessary LEEP in patients with colposcopic directed biopsy-confirmed CIN 2-3 who had low grade Pap results and low grade colposcopic impression. Therefore, conservative treatment may be another option for patients who have these predicting factors.
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